Indigenous Genes May Lead To New Drugs
Research into the genes of indigenous tribes and isolated groups could reveal insights leading to new and improved drugs and diagnostics. Andrew Farnham, CEO of a Seattle-based company, is involved in this research.
Topics
Developing
- 862d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 862d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 862d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 862d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
KQED FM
“it comes to what the genes of indigenous tribes and isolated groups might reveal and what can lead to new and better drugs and diagnostics. Andrew Farnham is the CEO of Seattle's”
KQED FM
“and better drugs and diagnostics. Andrew Farnham is the CEO of Seattle's variant bio. And Dr. Sarah LaBaron Bonbier is variant senior director of ethics and engagement.”
KQED FM
“about today is a different story than you the listener might suspect. No, it is not about taking the age-old treatments of indigenous tribes and making modern drugs out of them. No, this is a story about ethics in the m-”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade